What is APGE's dilution risk score?

APGE has a latest available DilutionScore record of 39/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for APGE, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for APGE?

DilutionWatch tracks 25 SEC filing types for APGE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect APGE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For APGE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for APGE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for APGE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

APGE Dilution Risk Score: 39/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

66

💰 Cash Runway

0

📊 Float Risk

20

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 9%

💰 Capital Raise model 18%

• Active ATM program with $350M remaining capacity

🔔 Track APGE — Get forecast alerts →

Market Data

Market Cap$6.19B

Shares Outstanding75.34M

Float57.83M

Cash$971.93M

Debt$8.05M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 27.7% shares (2026Q1 vs prior)

231 institutional holders · 93.05M shares

#1 T. Rowe Price Investment Management, Inc. 10.30M shares

#2 FMR LLC 9.26M shares

#3 Venrock Adviser, LLC 8.49M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.22M

Days to Cover4.0

% of Float7.3%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

4 INSIDER TRANSACTION 2026-04-10

4 INSIDER TRANSACTION 2026-04-03

4 INSIDER TRANSACTION 2026-03-27

8-K 8K EVENT 2026-03-25

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual APGE Dilution Snapshot

Apogee Therapeutics, Inc. (APGE) has a DilutionScore of 39/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $350.0M.
Recent SEC activity tracked for APGE: 4 on 2026-04-10; 4 on 2026-04-03; 4 on 2026-04-03.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.